{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:49:14Z","timestamp":1792273754691,"version":"4.4.0"},"reference-count":43,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Ann Clin Transl Neurol"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To evaluate plasma phosphorylated neurofilament heavy chain (\n                      <jats:styled-content style=\"fixed-case\">pNF<\/jats:styled-content>\n                      \u2010H) as a biomarker in spinal muscular atrophy (\n                      <jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Levels of\n                      <jats:styled-content style=\"fixed-case\">pNF<\/jats:styled-content>\n                      \u2010H were measured using the ProteinSimple\n                      <jats:sup>\u00ae<\/jats:sup>\n                      platform in plasma samples from infants with\n                      <jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content>\n                      enrolled in\n                      <jats:styled-content style=\"fixed-case\">ENDEAR<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">NCT<\/jats:styled-content>\n                      02193074) and infants\/children without neurological disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median\n                      <jats:styled-content style=\"fixed-case\">pNF<\/jats:styled-content>\n                      \u2010H plasma level was 167.0\u00a0pg\/mL (7.46\u20137,030; n\u00a0=\u00a034) in children without\n                      <jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content>\n                      (aged 7\u00a0weeks\u201318\u00a0years) and was higher in those aged\u00a0&lt;\u00a01 versus 1\u201318\u00a0years (\n                      <jats:italic>P\u00a0=\u00a0<\/jats:italic>\n                      0.0002). In\n                      <jats:styled-content style=\"fixed-case\">ENDEAR<\/jats:styled-content>\n                      participants with infantile\u2010onset\n                      <jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content>\n                      , median baseline\n                      <jats:styled-content style=\"fixed-case\">pNF<\/jats:styled-content>\n                      \u2010H level (15,400\u00a0pg\/mL; 2390\u201350,100;\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0117) was ~10\u2010fold higher than that of age\u2010matched infants without\n                      <jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content>\n                      (\n                      <jats:italic>P\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.0001) and ~90\u2010fold higher than children without\n                      <jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content>\n                      (\n                      <jats:italic>P\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.0001). Higher pretreatment\n                      <jats:styled-content style=\"fixed-case\">pNF<\/jats:styled-content>\n                      \u2010H levels in infants with\n                      <jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content>\n                      were associated with younger age at symptom onset, diagnosis, and first dose; lower baseline Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders score; and lower peroneal compound muscle potential amplitude. Nusinersen treatment was associated with a rapid and greater decline in\n                      <jats:styled-content style=\"fixed-case\">pNF<\/jats:styled-content>\n                      \u2010H levels: nusinersen\u2010treated infants experienced a steep 71.9% decline at 2\u00a0months to 90.1% decline at 10\u00a0months; sham control\u2013treated infants declined steadily by 16.2% at 2\u00a0months and 60.3% at 10\u00a0months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>\n                      Plasma\n                      <jats:styled-content style=\"fixed-case\">pNF<\/jats:styled-content>\n                      \u2010H levels are elevated in infants with\n                      <jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content>\n                      . Levels inversely correlate with age at first dose and several markers of disease severity. Nusinersen treatment is associated with a significant decline in\n                      <jats:styled-content style=\"fixed-case\">pNF<\/jats:styled-content>\n                      \u2010H levels followed by relative stabilization. Together these data suggest plasma\n                      <jats:styled-content style=\"fixed-case\">pNF<\/jats:styled-content>\n                      \u2010H is a promising marker of disease activity\/treatment response in infants with SMA.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/acn3.779","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:10:02Z","timestamp":1555546202000},"page":"932-944","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":206,"title":["Neurofilament as a potential biomarker for spinal muscular atrophy"],"prefix":"10.1002","volume":"6","author":[{"given":"Basil T.","family":"Darras","sequence":"first","affiliation":[{"name":"Department of Neurology Boston Children's Hospital and Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas O.","family":"Crawford","sequence":"additional","affiliation":[{"name":"Department of Neurology Johns Hopkins University School of Medicine Baltimore Maryland"},{"name":"Department of Pediatrics Johns Hopkins University School of Medicine Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Finkel","sequence":"additional","affiliation":[{"name":"Division of Neurology Department of Pediatrics Nemours Children's Hospital Orlando Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology Catholic University Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl C.","family":"De Vivo","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Pediatrics Columbia University Irving Medical Center New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Oskoui","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurosurgery and Department of Pediatrics McGill University Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo F.","family":"Tizzano","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Genetics and Rare Diseases Unit Hospital Vall d\u2032Hebron and Centro de Investigac\u00edon Biom\u00e9dica en Red Enfermedades Raras (CIBERER) Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Royal Children's Hospital Murdoch Children's Research Institute and University of Melbourne Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[{"name":"Dubowitz Neuromuscular Centre University College London London United Kingdom"},{"name":"NIHR Great Ormond Street Hospital Biomedical Research Centre London United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Biogen Cambridge Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Staropoli","sequence":"additional","affiliation":[{"name":"Biogen Cambridge Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"McCampbell","sequence":"additional","affiliation":[{"name":"Biogen Cambridge Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Petrillo","sequence":"additional","affiliation":[{"name":"Biogen Cambridge Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Stebbins","sequence":"additional","affiliation":[{"name":"Biogen Cambridge Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Fradette","sequence":"additional","affiliation":[{"name":"Biogen Cambridge Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wildon","family":"Farwell","sequence":"additional","affiliation":[{"name":"Biogen Cambridge Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte J.","family":"Sumner","sequence":"additional","affiliation":[{"name":"Department of Neurology Johns Hopkins University School of Medicine Baltimore Maryland"},{"name":"Department of Neuroscience Johns Hopkins University School of Medicine Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-417044-5.00008-1"},{"key":"e_1_2_8_3_1","unstructured":"Spinraza 12\u00a0mg solution for injection [summary of product characteristics].http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/004312\/WC500229704.pdf. Accessed June 4 2018."},{"key":"e_1_2_8_4_1","unstructured":"Spinraza [package insert]. Cambridge MA: Biogen 2018."},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702752"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710504"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2018.01.003"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-803685-3.00024-0"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018309"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.03.015"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(87)90049-X"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24552"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512443092"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306789"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821432ff"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2008.05.001"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164625"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004683"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.6117"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25276"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004932"},{"key":"e_1_2_8_22_1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1212\/WNL.0000000000006357","article-title":"NfL is a biomarker for adult\u2010onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"91","author":"Hayer SN","year":"2018","journal-title":"Neurology"},{"key":"e_1_2_8_23_1","unstructured":"ProteinSimple.ProteinSimple NF\u2010H specification sheet.https:\/\/www.proteinsimple.com\/documents\/NF-H_Specification_Sheet_Rev_B.pdf. Accessed June 4 2018."},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4493"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2014-0274"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181f85a03"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.07.043"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1191\/1352458504ms1021sr"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.017236"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.04.032"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2009.06386.x"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0058-z"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-803685-3.00002-1"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/cm.20488"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-010-0095-5"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2016.00006"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303768"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316605"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-307672"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.283"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20473"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25101"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND-180304"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001777"}],"container-title":["Annals of Clinical and Translational Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facn3.779","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acn3.779","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acn3.779","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acn3.779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T11:58:47Z","timestamp":1694347127000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/acn3.779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1002\/acn3.779"],"URL":"https:\/\/doi.org\/10.1002\/acn3.779","archive":["Portico"],"relation":{},"ISSN":["2328-9503","2328-9503"],"issn-type":[{"value":"2328-9503","type":"print"},{"value":"2328-9503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]},"assertion":[{"value":"2019-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}